268 related articles for article (PubMed ID: 16253609)
1. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil citrate therapy for pulmonary arterial hypertension.
Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil for primary and secondary pulmonary hypertension.
Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
[TBL] [Abstract][Full Text] [Related]
9. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
[No Abstract] [Full Text] [Related]
12. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Ghofrani HA; Grimminger F
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
[TBL] [Abstract][Full Text] [Related]
19. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]